{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-037078","form_type":"8-K","ticker":"VCNX","cik":"0001205922","company_name":"VACCINEX, INC.","filed_at":"2024-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.589135+00:00","generated_at":"2026-06-06T00:48:33.285461+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vaccinex implements 1-for-14 reverse stock split to regain Nasdaq minimum bid price compliance","bullets":["Split effective 5:00 p.m. ET Feb 19, 2024; shares trade split-adjusted from Feb 20.","Ratio 1-for-14, approved by board and stockholders; new CUSIP 918640301.","Complying with $1.00 minimum bid price required by Nasdaq by March 4, 2024.","Fractional shares rounded up; authorized shares unchanged; equity awards adjusted.","Shares continue trading under symbol VCNX; transfer agent is Computershare."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-037078","json":"https://secwatch.observer/filing/0001193125-24-037078.json","markdown":"https://secwatch.observer/filing/0001193125-24-037078.md","text":"https://secwatch.observer/filing/0001193125-24-037078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1205922/000119312524037078/0001193125-24-037078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1205922/000119312524037078/d754295d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T00:48:33.285461+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c726aca7f3654bb10d17df830cd9727c82b36466","claim":"VACCINEX, INC.: Implemented a 1-for-14 reverse stock split of the Company's issued common stock, effective at 5:00 p.m. Eastern Time on February 19, 2024, via a Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective 2024-02-19).","evidence_excerpt":"On February 14, 2024, Vaccinex, Inc. (the “Company”) filed a Certificate of Amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, as amended, with the Delaware Secretary of State to implement a reverse stock split of the Company’s issued shares of common stock at a ratio of 1-for-14, effective at 5:00 p.m. Eastern Time on Monday February 19, 2024 (the “Reverse Stock Split”), previously approved by the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1205922/000119312524037078/0001193125-24-037078-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-02-19"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}